Lexpos News

Twenty community pharmacies across South West London have participated in a Tympahealth (hearing health) pilot. The pilot aimed to test the provision of a more efficient pathway for ear health care that could be delivered away from secondary care, reducing outpatient spend and providing better quality care at a lower cost. The service launched in [...]

The post Service case study: Southwest London Hearing Health Pilot appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lamotrigine 5mg dispersible tablets. MSN/2023/100 Tier 2 – medium impact Date of issue 24th October 2023 Generic lamotrigine 5mg dispersible tablets are out of stock until mid-February 2024. Branded lamotrigine (Lamictal®) 2mg and 5mg dispersible tablets remain available but cannot fully [...]

The post Medicine Supply Notification: Lamotrigine 5mg dispersible tablets appeared first on Community Pharmacy England.

Pharmacy press 95% of hospital pharmacists across Europe are experiencing medicine shortages, according to a new report. The report, by the European Association of Hospital Pharmacists, found that hospital pharmacists across 58 countries reported that medicines shortages had delayed or cancelled care. We were asked to comment on the report’s findings, and on how the [...]

The post Medicine shortages across Europe appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bisacodyl (Dulcolax®) 5mg suppositories. MSN/2023/099 Tier 2 – medium impact Date of issue 23rd October 2023 Bisacodyl (Dulcolax®) 5mg suppositories are out of stock until w/c 18th December 2023. Glycerol 2g (children’s size) suppositories remain available but are unable to support [...]

The post Medicine Supply Notification: Bisacodyl (Dulcolax®) 5mg suppositories appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Zinacef powder for solution for injection or infusion vials (all strengths, including stock in GSK livery) (Sandoz Limited) Drug alert number:EL (23)A/38 Date issued: 23 October 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zinacef powder for solution for [...]

The post Class 4 Medicines Defect Information: Zinacef powder for solution for injection or infusion vials (Sandoz Limited) appeared first on Community Pharmacy England.